Peter Button
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Oncology 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- George Lau (3 shared papers)Teerha Piratvisuth (5 shared papers)Patrick Marcellin (3 shared papers)Yeul Hong Kim (1 shared paper)Sung Hoon Noh (1 shared paper)Keun‐Wook Lee (1 shared paper)Florin Sirzén (1 shared paper)Young‐Woo Kim (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Journal of Hepatology (3 papers)Cancer Research (2 papers)Annals of Oncology (2 papers)Hepatology International (1 paper)
- Partner nations
- AustraliaSwitzerlandUnited Kingdom
In The Last Decade
Peter Button
30 papers receiving 2.9k citations
Peter Button's Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 811
- Gastroenterology 252
- Pulmonary and Respiratory Medicine 1.2k
- Epidemiology 1.1k
- Oncology 464
Countries citing papers authored by Peter Button
This map shows the geographic impact of Peter Button's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Button with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Button more than expected).
Fields of papers citing papers by Peter Button
This network shows the impact of papers produced by Peter Button. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Button. The network helps show where Peter Button may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Button, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Hit paper breakdown → | 2012 | 1274 |
| 2 | Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Hit paper breakdown → | 2004 | 880 |
| 3 | 2008 | 188 | |
| 4 | 2015 | 176 | |
| 5 | 2009 | 100 | |
| 6 | 2012 | 65 | |
| 7 | 2008 | 65 | |
| 8 | 2015 | 45 | |
| 9 | 2018 | 35 | |
| 10 | 2014 | 33 | |
| 11 | 2012 | 29 | |
| 12 | 2017 | 23 | |
| 13 | 2017 | 19 | |
| 14 | 2014 | 14 | |
| 15 | 2015 | 14 | |
| 16 | 2022 | 12 | |
| 17 | 2019 | 11 | |
| 18 | 1997 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 2009 | 6 |
About Peter Button
Peter Button is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Hepatology and Rheumatology, having authored 33 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), HER2/EGFR in Cancer Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Hepatitis C virus research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hepatology (811 citations), Gastroenterology (252 citations), Pulmonary and Respiratory Medicine (1.2k citations), Epidemiology (1.1k citations) and Oncology (464 citations). Peter Button has collaborated with scholars based in Australia, Switzerland and United Kingdom. Frequent co-authors include George Lau, Teerha Piratvisuth, Patrick Marcellin, Yeul Hong Kim, Sung Hoon Noh, Keun‐Wook Lee, Florin Sirzén, Young‐Woo Kim, Yong Ho Kim and Jiafu Ji. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Cancer Research, Annals of Oncology and Hepatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.